Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Go back to Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
(NASDAQ: KNSA) Delayed: 57.13 --0 (-0%)
Previous Close $57.13    52 Week High
Open $57.13    52 Week Low
Day High $57.13    P/E N/A 
Day Low $57.13    EPS
Volume